A study of NeoBOMB1 for the treatment of prostate cancer.
Phase of Trial: Phase I
Latest Information Update: 14 Jul 2016
At a glance
- Drugs NeoBOMB1 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 14 Jul 2016 New trial record
- 07 Jun 2016 According to an Advanced Accelerator Applications media release, the company will present data from this study at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2016 Annual Meeting.